Examination of patients with advanced non-small cell lung cancer (NSCLC) responding to nivolumab monotherapy over 1 year

被引：0
|
作者：
Nakajima, Saki [1 ]
Watanabe, Satoshi [1 ,2 ]
Utsunomiya, Takuhide [1 ,2 ]
Yoshinoya, Kiyokazu [1 ,2 ]
Honda, Hidehiro [1 ,2 ]
Yamamoto, Suguru [2 ]
Kudo, Keita [1 ]
机构：
[1] Osaka Minami Med Ctr, Natl Hosp Org, Dept Thorac Med Oncol, Osaka, Japan
[2] Osaka Minami Med Ctr, Natl Hosp Org, Dept Resp Med, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P61-5
引用
收藏
页码：S536 / S536
页数：1
相关论文
共 50 条
  • [1] Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology
    Sankawa, Yuri
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (03) : 149 - 149
  • [2] Nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC) in routine clinical practice in a Spanish center
    Mielgo, X.
    Toro, P.
    Ruiz-Gimenez, L.
    Olier, C.
    Perez, M.
    Rosero, A.
    Camara, J. C.
    Hernando, S.
    Hurtado, A.
    Jara, C.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S135
  • [3] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [5] Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy
    Ruiz-Banobre, Juan
    Areses-Manrique, Maria C.
    Mosquera-Martinez, Joaquin
    Cortego, Alexandra
    Afonso-Afonso, Francisco J.
    de Dios-Alvarez, Noemi
    Fernandez-Nunez, Natalia
    Azpitarte-Raposeiras, Cristina
    Amenedo, Margarita
    Santome, Lucia
    Luis Firvida-Perez, Jose
    Garcia-Campelo, Rosario
    Garcia-Gonzalez, Jorge
    Casal-Rubio, Joaquin
    Vazquez, Sergio
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1078 - +
  • [6] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea.
    Park, Keunchil
    Cho, Eun Kyung
    Kang, Jin Hyoung
    Han, Ji-Youn
    Lee, Jong Seok
    Kim, Dong-Wan
    Kim, Sang-We
    Cho, Byoung Chul
    Min, Young Joo
    Lee, Ki Hyeong
    Kim, Joo-Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [7] Outcomes of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) in A Regional Australian Population
    Kasherman, Lawrence
    Brungs, Daniel
    Bell, Graeme
    Glasgow, Amanda L.
    Tafreshi, Ali
    Clingan, Philip
    Aghmesheh, Morteza
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 145 - 146
  • [8] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [9] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [10] First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses
    Gettinger, S. N.
    Hellmann, M. D.
    Shepherd, F. A.
    Antonia, S. J.
    Brahmer, J.
    Chow, L. Q.
    Goldman, J.
    Juergens, R.
    Borghaei, H.
    Ready, N. E.
    Gerber, D. E.
    Nathan, F.
    Shen, Y.
    Harbison, C. T.
    Rizvi, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S632 - S632
12345